Westphal's team is now crafting compounds that have more potent sirt1-activating effects than resveratrol, hoping they might help tackle diabetes and Alzheimer's.
Puigserver and his colleagues found that SIRT1, the mammal version of the SIR2 gene, was turned on in the livers of mice when they were put on a calorie-restricted diet.